Recent Progress in Upconversion Photodynamic Therapy
AbstractPhotodynamic therapy (PDT) is a minimally invasive cancer modality that combines a photosensitizer (PS), light, and oxygen. Introduction of new nanotechnologies holds potential to improve PDT performance. Upconversion nanoparticles (UCNPs) offer potentially advantageous benefits for PDT, attributed to their distinct photon upconverting feature. The ability to convert near-infrared (NIR) light into visible or even ultraviolet light via UCNPs allows for the activation of nearby PS agents to produce singlet oxygen, as most PS agents absorb visible and ultraviolet light. The use of a longer NIR wavelength permits light to penetrate deeper into tissue, and thus PDT of a deeper tissue can be effectively achieved with the incorporation of UCNPs. Recent progress in UCNP development has generated the possibility to employ a wide variety of NIR excitation sources in PDT. Use of UCNPs enables concurrent strategies for loading, targeting, and controlling the release of additional drugs. In this review article, recent progress in the development of UCNPs for PDT applications is summarized. View Full-Text
Share & Cite This Article
Qiu, H.; Tan, M.; Ohulchanskyy, T.Y.; Lovell, J.F.; Chen, G. Recent Progress in Upconversion Photodynamic Therapy. Nanomaterials 2018, 8, 344.
Qiu H, Tan M, Ohulchanskyy TY, Lovell JF, Chen G. Recent Progress in Upconversion Photodynamic Therapy. Nanomaterials. 2018; 8(5):344.Chicago/Turabian Style
Qiu, Hailong; Tan, Meiling; Ohulchanskyy, Tymish Y.; Lovell, Jonathan F.; Chen, Guanying. 2018. "Recent Progress in Upconversion Photodynamic Therapy." Nanomaterials 8, no. 5: 344.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.